SPOTLIGHT -
Tampere, Finland-Both the M2 Single Use microkeratome and the M2 microkeratome with the new 90-?m head (Moria, Antony, France) have been performing well in clinical trials.
Verana Health launches its Qdata Thyroid Eye Disease module
(EyePod) From idea to impact: Navigating ophthalmic innovation
Phoenix-Micron Inc and ArtiKode Intelligence team up to enhance OCT imaging with AI
EyePod: Modifier Gene Therapy: What is it?
Orbis, FundamentalVR team up to target training
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410